Pharma IQ | 12/06/2010
Dr. David Hay, Principal Investigator at the MRC Centre for Regenerative Medicine, joins Helen Winsor from Pharma IQ, to discuss the challenges and potential of metabolically active hepatocytes, covering the following areas:Insights into polymer screening to identify culture matrices which can regulate cell phenotypesHow to achieve stability using a novel polymer matrixHow high through-put polymer screening can be applied to enhance the stability of stem cell modelsThe future development of stem...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More